Status:
COMPLETED
By Potentially Adding a Century Old Therapeutic Measure to Pain Treatment Regimens Called Osteopathic Manipulative Treatment, Can Help Decrease Muscle and Bone Pain and the Usage of Opioid Pain Medication.
Lead Sponsor:
Skagit Regional Health
Collaborating Sponsors:
Philadelphia College of Osteopathic Medicine
University of Eastern Finland
Conditions:
Osteopathic Manipulative Treatment
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Osteopathic Manipulative Treatment (OMT) has been used to successfully treat patients for over a hundred years. Even though there have been many subjective clinical results, there is still little rese...
Detailed Description
Subjects will randomly choose a number 1-3. The number correlates to one of three treatment techniques ME, CS, or HVLA. Prior to treatment subjects will be analyzed with the Ultralign SA201 to the cer...
Eligibility Criteria
Inclusion
- The subjects that will be sought for this study will be male or female subjects from the ages of 18-65 years. Because this is a one session study, where a person lives does not preclude them from participating in this study.
- Healthy Volunteers are the volunteers that may present with or without a cervical somatic dysfunction, having a cervical somatic dysfunction is a common biomechanical occurrence and does not constitute a person as being unhealthy.
Exclusion
- Subjects younger than age 18 or over the age of 65 years.
- History of abnormal findings on brain or cervical CT/MRI
- History of diagnosis of symptomatic osteoarthritis of the cervical spine (as documented in previous imaging studies) or as evidenced by palpation and provocative tests during structural exam
- Significant scoliosis that contributes to back or neck pain diagnosed by structural exam
- Current diagnosis or history of depression, except for mild situational depression specifically diagnosed as associated with chronic headaches
- Significant psychiatric disorders present or past including, but not limited to: borderline personality, bipolar disorder or schizophrenia
- History of systemic disease which includes, but is not limited to: rheumatoid arthritis, Marfan's syndrome, fibromyalgia, Ehler-Danlos Syndrome or other connective tissue disease, lupus or ankylosing spondylitis
- History of neoplastic disease
- Involvement in current litigation involving the neuromusculoskeletal syndrome
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2012
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT06930196
Start Date
June 1 2011
End Date
June 30 2012
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania, United States, 19131